Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer | BMC Cancer | Full Text

Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer | BMC Cancer | Full Text

Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer

Solute Carrier Family 6 Member 1 (SLC6A1) has been identified as a cancer-promoting gene in various human cancers, such as clear cell renal cell carcinoma and ovarian cancer. However, its roles in prostate can...

Authors:Chaojiang Chen, Zhiduan Cai, Yangjia Zhuo, Ming Xi, Zhuoyuan Lin, Funeng Jiang, Zezhen Liu, Yueping Wan, Yu Zheng, Jianxin Li, Xing Zhou, Jianguo Zhu and Weide Zhong

Citation:BMC Cancer 2020 20:289

Content type:Research article

Published on: 6 April 2020

• ViewFull Text
 
• ViewPDF